In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination

In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination

Significant recent advances in cancer immunotherapeutics include the vaccination of cancer patients with tumor antigen-associated peptide-pulsed dendritic cells (DCs). DC vaccines with homogeneous, mature, and functional activities are required to achieve effective acquired immunity; however, the yi...

Full description

Bibliographic Details
Main Authors: Shigetaka Shimodaira, Ryu Yanagisawa, Terutsugu Koya, Koichi Hirabayashi, Yumiko Higuchi, Takuya Sakamoto, Misa Togi, Tomohisa Kato, Takashi Kobayashi, Tomonobu Koizumi, Shigeo Koido, Haruo Sugiyama
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Vaccines
Subjects:
dendritic cell
cancer vaccine
vaccination
acquired immunity
granulocyte colony-stimulating factor
tetramer analysis
Online Access:https://www.mdpi.com/2076-393X/7/3/120

Internet

https://www.mdpi.com/2076-393X/7/3/120

Similar Items